Compound Detail
CHEMBL6021271
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COC(=O)CCn1c(=O)[nH]/c(=N\c2ccc(Oc3cccc(C#N)n3)cc2)n(Cc2ccc(Cl)cc2)c1=O
Basic Information
| ChEMBL ID | CHEMBL6021271 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZDHZAXPPIBGBGD-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
532.9
MW (Da)
2.89
ALogP
10
HBA
1
HBD
144.4
PSA (Ų)
0.34
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| P2X purinoceptor 3 CHEMBL2998 | IC50 | 8.7 | 8.7 | 2.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| P2X purinoceptor 3 | IC50 | = | 2.0 | nM | 8.7 | Human P2X3 Receptor Inhibition Assay: Stably expressing cell line (C6BU-1 transf... | - |
Data from ChEMBL 36 via Core Engine